BROSSARD, Quebec - September 5, 2025 - Diagnos Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a leader in early detection of major health problems through advanced AI technology, has successfully completed a non-brokered private placement deal. The placement, first revealed on September 3, 2025, involved the issuance of 10 units at a rate of $10,000 per Unit, resulting in total proceeds amounting to $100,000.